小檗果对高血压及心血管风险患者血压、血脂和炎症影响的研究方案
本研究为一项为期8周的前瞻性、单盲、平行随机对照试验,计划纳入高血压合并其他心血管风险因素的男女患者,随机分为安慰剂粉组(n=37)和小檗果粉组(n=37)。主要评估小檗果对血压、血脂和炎症标志物的影响,并监测24小时尿亚硝酸盐/硝酸盐及钠排泄。
要点
- 小檗果作为心脏保护性水果,其降压、降脂和抗炎作用尚需随机对照试验验证。
- 试验采用24小时动态血压监测和血浆炎症标志物作为客观评估指标。
- 研究结果将为小檗果在心血管疾病一级预防中的应用提供证据。
核心结论
- 本试验旨在探讨小檗果对高血压患者血压、血脂和炎症生物标志物的影响,目前尚未报告结果。
研究设计与样本
- 为期8周的前瞻性、单盲、平行随机对照临床试验,计划纳入高血压合并其他心血管风险因素的患者。
- 受试者随机分为安慰剂粉组(含9克麦芽糊精、1克柠檬酸、1克研磨蔗糖和食用红色素,n=37)和小檗果粉组(含10克研磨干燥小檗果和1克研磨蔗糖,n=37)。
关键数值与推荐
- 在基线和干预8周后测量血浆血脂和炎症标志物、24小时尿亚硝酸盐/硝酸盐和钠排泄,以及24小时动态血压监测。
- 同时进行人体测量学和膳食评估,数据分析使用SPSS版本21软件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiovascular diseases (CVDs) remain the leading causes of morbidity and mortality in the world. Hypertension is an important and prevalent cardiovascular risk factor. The present study will be conducted to investigate the effect of barberry as a cardio-protective fruit on the blood pressure in patients with hypertension and other CVD risk factors. Furthermore, plasma concentrations of lipids and inflammatory biomarkers will be evaluated. METHODS/DESIGN: This is an 8-week, prospective, single-blinded, parallel assigned, randomized controlled clinical trial (RCT) in which eligible men and women with hypertension and other cardiovascular risk factors will be randomized to either placebo powder (PP; containing 9 g maltodextrin, 1 g citric acid, 1 g milled sucrose and edible red color (n = 37)) or barberry powder (BP; containing 10 g milled dried barberry and 1 g of milled sucrose (n = 37)) groups. At baseline and after 8 weeks of intervention, plasma lipids and inflammatory markers, 24-h urinary nitrite/nitrate and sodium excretion, and 24-h ambulatory blood pressure monitoring (ABPM) will be measured. Anthropometric measures and dietary assessment will be performed as well. Data analysis will be done using SPSS version-21 software. DISCUSSION: The interest in natural and functional food products has increased globally. This RCT will add to the growing literature for the potential antihypertensive, lipid-lowering, and anti-inflammatory effects of barberry in humans. TRIAL REGISTRATION: ClinicalTrials.gov (NCT number) NCT04084847 . Registered on 10 December 2019.
引用
- Emamat H, Zahedmehr A, Asadian S, et al. Effect of barberry (Berberis vulgaris) consumption on blood pressure, plasma lipids, and inflammation in patients with hypertension and other cardiovascular risk factors: study protocol for a randomized clinical trial. Trials. 2020. PMID: 33246500. doi:10.1186/s13063-020-04918-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。